Trademark: 79384162
Word
IMMUNOPLUS
Status
Registered
Status Code
700
Status Date
Tuesday, June 11, 2024
Serial Number
79384162
Registration Number
7410943
Registration Date
Tuesday, June 11, 2024
Mark Type
5
Filing Date
Wednesday, September 13, 2023
Published for Opposition
Tuesday, March 26, 2024

Trademark Owner History
Nanjing GenScript Biotech Co., Ltd. - Original Registrant

Classifications
42 Scientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays; product quality testing; biochemical research and analysis; gene therapy research; dna screening for scientific research purposes; biological cloning services; biological research and analysis; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research in the field of genetics; biological research; development of gene-based medicines; research and development services in the field of antibodies
The mark consists of the stylized wording "IMMUNOPLUS".

Trademark Events
Nov 30, 2023
Sn Assigned For Sect 66a Appl From Ib
Dec 13, 2023
Limitation From Original Application Entered
Dec 18, 2023
New Application Office Supplied Data Entered
Dec 22, 2023
Application Filing Receipt Mailed
Feb 16, 2024
Assigned To Examiner
Feb 20, 2024
Approved For Pub - Principal Register
Mar 26, 2024
Published For Opposition
Mar 6, 2024
Notice Of Publication
Jun 11, 2024
Registered-Principal Register
Jul 11, 2024
Final Disposition Notice Created, To Be Sent To Ib

Trademark Alertz updated from USPTO on 2030-01-24